Clinical Trials Logo

Clinical Trial Summary

Preoperative anemia is a known risk factor for morbidity, mortality and increased healthcare resource utilisation. The Investigator's previous study demonstrated the rate of preoperative anemia in Singapore General Hospital (SGH) to be at 26.6%. The rate is highest in the elderly group which stands at 49.9%. The main objective of this study is to investigate the perioperative morbidity and mortality, blood transfusion rate, healthcare outcomes and patient-centric outcomes among anemic elderly patients undergoing major surgery. The investigators hypothesize that elderly patients who undergoes major abdominal surgery with preoperative anemia will have higher composite morbidity and mortality rates (primary outcome), longer length of hospital stay, higher blood transfusion requirements and lower health-related quality of life (HRQoL) at 1, 3 and 6 months (secondary outcomes) when compared to elderly patients without preoperative anemia. The investigators will conduct a prospective observational study of 450 consecutive patients above 65 years, who are undergoing elective major open abdominal surgery in SGH over 12 months. Baseline clinical assessment, including iron studies for anemic patients, will be done within 14 days prior to surgery. To determine the primary outcome, patients will be followed up prospectively for 30 days from the day of surgery. This will be done via a mixture of medical records review and phone interview. For secondary outcomes, the length of hospital stay and readmissions for any reason within 3 and 6 months will be recorded.

HRQoL questionnaires will be done through phone calls by a study team member. Findings from this study will hopefully fill the knowledge gaps such as how anemia impacts elderly people in terms of perioperative morbidity, mortality, postsurgical quality of life and their eventual return to the community as well as providing local data on the healthcare resource utilisation in this group.


Clinical Trial Description

Preoperative anemia is a common and important problem in the elderly.

Many studies have established association between preoperative anemia and poor postoperative outcomes. Some propose that preoperative anemia is an independent risk factor of adverse outcomes. Preoperative anemia is also one of the strongest predictors of perioperative blood transfusion which is independently associated with increased risk of perioperative morbidity and mortality. Consequently, preoperative anemia increases healthcare utilization and costs due to increased blood transfusion requirements, prolonged length of hospital stay and hospital readmission rates. As more elderly patients undergo surgery yearly, there is a need to improve perioperative outcome, contain healthcare costs and help rapid return to community. Addressing preoperative anemia could be one such strategy as it may lead to decreased need for blood transfusion, and reduction of morbidity and mortality, and improved health-related quality of life. The relationship between anemia and quality of life is well documented in patients with cancer and with end-stage renal failure, but not so well examined in elderly postoperative patients.

The primary aim of this study is to investigate the impact of preoperative anemia on postoperative complications as defined by presence of Postoperative Morbidity Survey (POMS) defined complications at day 5. The 9 domains within POMS allow classification of complications into various organ categories, such as cardiac, respiratory, infectious etc. The secondary aim of this study is to investigate the impact of preoperative anemia on the severity of post operative complications as classified with the Clavien Dindo Classification and Comprehensive Complication Index.

Other secondary aims of this study include investigating the association between preoperative anemia and length of hospital stay, readmission within 6 months, days alive and out of hospital (DaOH) within 6 months, and 30-day mortality. Data generated on the potential healthcare costs of this modifiable risk factor would help to provide the background for future studies on intervention strategies and its cost effectiveness.

Another secondary aim of the study is to examine the relationship between preoperative anemia and baseline and postoperative health-related quality of life indices up to 6 months postoperative using the EQ-5D questionnaire. The results of this study will encourage policies that risk profile patients who may require extra support on returning to the community. In the longer term, the investigators hope to spur studies which look at the optimal hemoglobin level prior to hospital discharge after surgery.

Significance of the Study

The findings from this study will have a significant impact on the way clinicians and researchers approach preoperative anemia in the elderly. The full clinical, patient-centred, and economic impact of operating on an anemic elderly patient has not been clearly elucidated, especially in the local context. In the longer term, this study may set the foundation for nationwide policies to address anemia in the surgical population with the aim of improving patient outcomes in the most cost effective manner. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03497416
Study type Observational
Source Singapore General Hospital
Contact Brenda Tan Clinical Research Coordinator
Phone 90212443
Email brenda.tan.p.y@sgh.com.sg
Status Recruiting
Phase
Start date October 3, 2017
Completion date October 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Recruiting NCT03341338 - Genes-in-Action - Hepcidin Regulation of Iron Supplementation
Recruiting NCT02101944 - Wild-type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Phase 1
Not yet recruiting NCT02851472 - Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO Phase 1/Phase 2
Recruiting NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Angiodysplasias Phase 2/Phase 3
Completed NCT02603250 - Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda N/A
Completed NCT02260193 - 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Subjects With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis Phase 2
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT02310113 - Transfusion and Skeletal Muscle Tissue Oxygenation N/A
Withdrawn NCT01934842 - A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate N/A
Completed NCT01922479 - Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure Phase 4
Completed NCT01693029 - Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa Phase 3
Completed NCT01432717 - Study of ACE-536 in Healthy Postmenopausal Women Phase 1
Terminated NCT01535781 - Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced? N/A
Completed NCT01458028 - Age and Gender Effects on the Pharmacokinetics of BAY85-3934 Phase 1
Completed NCT02817555 - Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients Phase 4
Completed NCT01191463 - The Efficacy of a Local Vitamin-C Rich Fruit (Guava) in Improving Iron Absorption From Mungbean Based Meals and Its Effect on Iron Status of Rural Indian Children (6-10 Years) N/A
Completed NCT01309269 - Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine N/A
Completed NCT01356589 - A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL) N/A
Completed NCT01208363 - Improving Iron Status Through Consumption Of Iron Fortified Cowpea: An Intervention Study N/A